These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6142065

  • 1. The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii.
    Cisar JO, Sandberg AL, Mergenhagen SE.
    J Dent Res; 1984 Mar; 63(3):393-6. PubMed ID: 6142065
    [Abstract] [Full Text] [Related]

  • 2. Actinomyces adsorption mediated by type-1 fimbriae.
    Clark WB, Wheeler TT, Lane MD, Cisar JO.
    J Dent Res; 1986 Sep; 65(9):1166-8. PubMed ID: 2874164
    [Abstract] [Full Text] [Related]

  • 3. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB, Webb EL, Wheeler TT, Fischlschweiger W, Birdsell DC, Mansheim BJ.
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [Abstract] [Full Text] [Related]

  • 4. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE, Sandberg AL, Chassy BM, Brennan MJ, Yeung MK, Donkersloot JA, Cisar JO.
    Rev Infect Dis; 1987 Sep; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [Abstract] [Full Text] [Related]

  • 5. In vitro attachment, salivary agglutination, and surface fibril density of fresh Actinomyces isolates from two distinct oral surfaces.
    Ellen RP, Sivendra R.
    J Dent Res; 1985 May; 64(5):799-803. PubMed ID: 2860145
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE, Beem JE, Leung KP, Stroup S, Swift R, McArthur WP, Clark WB.
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [Abstract] [Full Text] [Related]

  • 7. Chemical and immunological comparison of surface fibrils of strains representing six taxonomic groups of Actinomyces viscosus and Actinomyces naeslundii.
    Masuda N, Ellen RP, Fillery ED, Grove DA.
    Infect Immun; 1983 Mar; 39(3):1325-33. PubMed ID: 6188696
    [Abstract] [Full Text] [Related]

  • 8. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Qureshi JV, Gibbons RJ.
    Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448
    [Abstract] [Full Text] [Related]

  • 9. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO, David VA, Curl SH, Vatter AE.
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [Abstract] [Full Text] [Related]

  • 10. Actinomyces viscosus fibril antigens detected by immunogold electron microscopy.
    Ellen RP, Buivids IA, Simardone JR.
    Infect Immun; 1989 Apr; 57(4):1327-31. PubMed ID: 2564376
    [Abstract] [Full Text] [Related]

  • 11. The use of monoclonal antibodies in the study of lactose-sensitive adherence of Actinomyces viscosus T14V.
    Cisar JO, Barsumian EL, Curl SH, Vatter AE, Sandberg AL, Siraganian RP.
    J Reticuloendothel Soc; 1980 Dec; 28(Suppl):73s-79s. PubMed ID: 6108369
    [No Abstract] [Full Text] [Related]

  • 12. A study of in vitro attachment of Streptococcus sanguis and Actinomyces viscosus to saliva-treated titanium.
    Wolinsky LE, de Camargo PM, Erard JC, Newman MG.
    Int J Oral Maxillofac Implants; 1989 Dec; 4(1):27-31. PubMed ID: 2599579
    [Abstract] [Full Text] [Related]

  • 13. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Peros WJ, Gibbons RJ.
    Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480
    [Abstract] [Full Text] [Related]

  • 14. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ, Vatter AE, Crowle AJ, Cisar JO.
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [Abstract] [Full Text] [Related]

  • 15. Coaggregation of human oral Cytophaga species and Actinomyces israelii.
    Kolenbrander PE, Celesk RA.
    Infect Immun; 1983 Jun; 40(3):1178-85. PubMed ID: 6133836
    [Abstract] [Full Text] [Related]

  • 16. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO, McIntire FC, Vatter AE.
    Adv Exp Med Biol; 1978 Jun; 107():695-701. PubMed ID: 84522
    [Abstract] [Full Text] [Related]

  • 17. Association of fimbriae with the hydrophobicity of Streptococcus sanguis FC-1 and adherence to salivary pellicles.
    Gibbons RJ, Etherden I, Skobe Z.
    Infect Immun; 1983 Jul; 41(1):414-7. PubMed ID: 6134679
    [Abstract] [Full Text] [Related]

  • 18. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO, Vatter AE, Clark WB, Curl SH, Hurst-Calderone S, Sandberg AL.
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [Abstract] [Full Text] [Related]

  • 19. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
    Kuramitsu HK, Paul A.
    Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
    [Abstract] [Full Text] [Related]

  • 20. Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.
    Brennan MJ, Cisar JO, Vatter AE, Sandberg AL.
    Infect Immun; 1984 Nov; 46(2):459-64. PubMed ID: 6150008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.